Cargando…

Long-term evaluation of the seroprevalence of SARS-CoV-2 IgG and IgM antibodies in recovered patients: a meta-analysis

Estimating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) -specific immunoglobulin G (IgG) immunoglobulin M (IgM) antibodies are increasingly important for tracking the spread of infection and defining herd immunity barrier and individual immunization levels in the ongoing coronavirus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qiu, Chen, Lu, Li, Fen, He, An
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314509/ https://www.ncbi.nlm.nih.gov/pubmed/37393304 http://dx.doi.org/10.1186/s12879-023-08425-3

Ejemplares similares

Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil
por: Borges, Lysandro Pinto, et al.
Publicado: (2020)

SARS-COV-2 IgG and IgM Antibodies in Cancer Patients
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19
por: Qin, Xuzhen, et al.
Publicado: (2021)

The seroprevalence of Mycoplasma pneumoniae IgM and IgG antibodies in patients with ischemic stroke
por: Roham, Maryam, et al.
Publicado: (2016)

Seroprevalence of CMV IgG and IgM in Korean women of childbearing age
por: Choi, Rihwa, et al.
Publicado: (2021)

Seroprevalence of IgM and IgG anti-SARS-COV-2 and associated factors among agricultural workers in Colombia
por: Rodríguez, M.F., et al.
Publicado: (2022)

Serologic Tests of IgG and IgM Antibodies and IgG Avidity for Diagnosis of Ocular Toxoplasmosis
por: Rahimi-Esboei, Bahman, et al.
Publicado: (2018)

Evaluation of Serologic Changes of IgG and IgM Antibodies Associated with SARS-COV-2 in Cancer Patients: A Cohort Seroprevalence Study
por: Arab, Maliheh, et al.
Publicado: (2021)

Association of dengue infection with anti-alpha-gal antibodies, IgM, IgG, IgG1, and IgG2
por: Olajiga, Olayinka M., et al.
Publicado: (2022)

Impact of heat-inactivation on the detection of SARS-CoV-2 IgM and IgG antibody by ELISA
por: Hu, Xiumei, et al.
Publicado: (2020)

IgM and IgG Immunoreactivity of SARS-CoV-2 Recombinant M Protein
por: Lopandić, Zorana, et al.
Publicado: (2021)

Investigation of Durability of SARS-CoV-2-specific IgG and IgM Antibodies in Recovered COVID-19 Patients: A Prospective Study
por: Zamani, Mohammad, et al.
Publicado: (2022)

Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients
por: Lee, Yu-Lin, et al.
Publicado: (2020)

Detection of IgM and IgG antibodies against SARS-CoV-2 in patients with autoimmune diseases
por: Teng, Jialin, et al.
Publicado: (2020)

Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies
por: Takahashi, Maika, et al.
Publicado: (2022)

Competition between Serum IgG, IgM, and IgA Anti-Glycan Antibodies
por: Muthana, Saddam M., et al.
Publicado: (2015)

Dynamic changes and prevalence of SARS-CoV-2 IgG/IgM antibodies: Analysis of multiple factors
por: Luo, Chunhua, et al.
Publicado: (2021)

IgG, IgM and IgA antibodies against the novel polyprotein in active tuberculosis
por: Feng, Xiaoyan, et al.
Publicado: (2014)

MONOCLONAL PRODUCTION OF BOTH IgM AND IgG1 ANTIHAPTEN ANTIBODY
por: Press, Joan L., et al.
Publicado: (1973)

Patterns of IgG and IgM antibody response in COVID-19 patients
por: Liu, Xuemei, et al.
Publicado: (2020)

Detection of IgM and IgG antibodies in patients with coronavirus disease 2019
por: Hou, Hongyan, et al.
Publicado: (2020)

Cross-sectional IgM and IgG profiles in SARS-CoV-2 infection
por: Ozturk, Tugba, et al.
Publicado: (2020)

Human IgM and IgG Responses to an Inactivated SARS-CoV-2 Vaccine
por: Banga Ndzouboukou, Jo-Lewis, et al.
Publicado: (2021)

Validation of rapid antibody (IgG-IgM) test kit for SARS-CoV-2 infection in Qatar
por: Mundodan, Jesha, et al.
Publicado: (2021)

Verification and Comparison of Qualitative Serological Assays for Anti-SARS-COV-2 IgM and IgG Antibodies Detection
por: Štebih, Maša, et al.
Publicado: (2022)

Comparison of in-house IgM and IgG ELISAs for the serodiagnosis of melioidosis in Malaysia
por: Hii, Shirley Yi Fen, et al.
Publicado: (2017)

Serum IgA, IgM, and IgG responses in COVID-19
por: Ma, Huan, et al.
Publicado: (2020)

Helper T cells reacting to idiotype on IgG but not IgM
Publicado: (1985)

Seroprevalence of rubella-specific IgM and IgG antibodies among pregnant women seen in a tertiary hospital in Nigeria
por: Olajide, Okikiola M, et al.
Publicado: (2015)

Seroprevalence of Anti-SARS-CoV-2 IgG and IgM among Adults over 65 Years Old in the South of Italy
por: Polvere, Immacolata, et al.
Publicado: (2021)

High Seroprevalence of Anti-SARS-CoV-2 IgM/IgG among Inhabitants of Sakaka City, Aljouf, Saudi Arabia
por: Taha, Ahmed E., et al.
Publicado: (2022)

High seroprevalence of Immunoglobulin G (IgG) and IgM antibodies to SARS-CoV-2 in asymptomatic and symptomatic individuals amidst vaccination roll-out in western Kenya
por: Awandu, Shehu Shagari, et al.
Publicado: (2022)

Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS‐associated coronavirus
por: Hsueh, P.‐R., et al.
Publicado: (2004)

Performance Characteristics of the Vidas SARS-CoV-2 IgM and IgG Serological Assays
por: Renard, Nathalie, et al.
Publicado: (2021)

Understanding the dynamics of IgM & IgG antibodies in COVID-19-positive patients
por: Kaduskar, Ojas, et al.
Publicado: (2022)

Long-Term Longitudinal Evaluation of Six Commercial Immunoassays for the Detection of IgM and IgG Antibodies against SARS CoV-2
por: Nedelcu, Iulia, et al.
Publicado: (2021)

Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients
por: Sun, Baoqing, et al.
Publicado: (2020)

Clinical significance of the serum IgM and IgG to SARS‐CoV‐2 in coronavirus disease‐2019
por: Wu, Li‐xiang, et al.
Publicado: (2020)

IgG, IgM, and IgA Antinuclear Antibodies in Discoid and Systemic Lupus Erythematosus Patients
por: Jost, Sheridan A., et al.
Publicado: (2014)

False positive Herpes Simplex IgM serology in COVID-19 patients correlates with SARS-CoV-2 IgM/IgG seropositivity
por: Vandervore, Laura, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pbjm40j4e8h0vbf07g7olgg733